Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Zomedica Corp. - news published 155 - readings 1.696

BACK

Zomedica Corp.

Zomedica Corp. Announces Transition to OTCQB Market (Form 8-K)

Zomedica Corp. Announces Transition to OTCQB Market Zomedica's ticker symbol will change to ZOMDF ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced ...

05.03.2025

Zomedica Corp.

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

February 26, 2025 11:30 AM Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica ...

26.02.2025

Zomedica Corp.

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSIO ...

25.02.2025

Zomedica Corp.

Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters

February 12, 2025 11:30 AM Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedic ...

12.02.2025

Zomedica Corp.

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis

February 6, 2025 11:30 AM Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, ...

06.02.2025

Zomedica Corp.

Initial Statement of Beneficial Ownership (Form 3)

Ownership Submission FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 (Print or T ...

03.01.2025

Zomedica Corp.

Statement of Changes in Beneficial Ownership (Form 4)

Ownership Submission FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES A ...

03.01.2025

Zomedica Corp.

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer Form 8 K

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer Seasoned executive brings a broad skill set to Zomedica's leadership team. ANN ARBOR, MI / ACCESSWIRE / December 19, 2023 / Zomedica Corp . (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and th ...

19.12.2024

Zomedica Corp.

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer

December 19, 2024 11:30 AM Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp. (NYSE American:ZOM ...

19.12.2024

Zomedica Corp.

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024

ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present and host one-on-one meetings with investors a ...

27.11.2024

Zomedica Corp.

Amendment to Statement of Changes in Beneficial Ownership - Form 4/A

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Zomedica Corp. published this content on November 26, 2024 , and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on November 26, 2024 at 22:37:10.219 .

26.11.2024

Zomedica Corp.

Material Agreement Form 8 K

Item 1.01. Entry into a Material Definitive Agreement. On November 15, 2024, Zomedica, Inc., a wholly-owned subsidiary of Zomedica Corp., entered into a Lease Agreement (the "Lease") with 1101 Technology Drive, L.L.C (the "Landlord") for property located at 1101 Technology Drive, Suite 100, Ann Arbor, MI 48108 (the "Leased Premises"). The Lease wi ...

19.11.2024

Zomedica Corp.

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform

Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI / ACCESSWIRE / November 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today anno ...

14.11.2024

Zomedica Corp.

Statement of Changes in Beneficial Ownership - Form 4

13.11.2024

Zomedica Corp.

Statement of Changes in Beneficial Ownership - Form 4

13.11.2024

Zomedica Corp. - news published 155 - readings 1.696

Zomedica Corp.

Zomedica Corp. Announces Transition to OTCQB Market (Form 8-K)

Zomedica Corp.

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

Zomedica Corp.

Statement of Changes in Beneficial Ownership (Form 4)

Zomedica Corp.

Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters

Zomedica Corp.

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis

Zomedica Corp.

Initial Statement of Beneficial Ownership (Form 3)

Zomedica Corp.

Statement of Changes in Beneficial Ownership (Form 4)

Zomedica Corp.

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer Form 8 K

Zomedica Corp.

Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer

Zomedica Corp.

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024

Zomedica Corp.

Amendment to Statement of Changes in Beneficial Ownership - Form 4/A

Zomedica Corp.

Material Agreement Form 8 K

Zomedica Corp.

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform

Zomedica Corp.

Statement of Changes in Beneficial Ownership - Form 4

Zomedica Corp.

Statement of Changes in Beneficial Ownership - Form 4

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member